-
CCHIO 2024 | Prof. Winckworth-Prejsnar: Advancing Evidence-Based Cancer Treatment through Global Collaboration
From November 14–17, the 2024 Chinese Congress of Holistic Integrative Oncology (CCHIO) and the Asian Oncology Society (AOS 2024) convened in Xi’an. Jointly organized by the Chinese Anti-Cancer Association (CACA), the Union for International Cancer Control (UICC), and the National Comprehensive Cancer Network (NCCN®), the event featured a specialized session on “International Collaboration: CACA-UICC & CACA-NCCN.”
-
CCHIO 2024 | Prof. Naoufal Louati: Unlocking the Potential of TCM in Cancer Care and Strengthening China-Morocco Collaboration
The 2024 Chinese Congress of Holistic Integrative Oncology (CCHIO) recently convened in Xi’an, bringing together global experts and scholars to discuss the latest advancements in cancer treatment and foster international cooperation. Among the distinguished participants was Prof. Naoufal Louati, President of the Moroccan Institute of Traditional Chinese Medicine, who delivered a keynote presentation titled “Global Progress…
-
The academic grand event on urological tumors is coming, and the live-streaming feast is about to begin!
Dear colleagues in the medical field, the 14th Shanghai Genitourinary Oncology Academic Conference & Annual Meeting of Chinese Anti-Cancer Association-Genital Oncology Committee (CACA-GO) will be held grandly from December 6th to 8th ! This is a “highlight moment” in the field of urology. It focuses on the cutting-edge progress and innovative achievements. Many top-notch experts…
-
AASLD 2024丨Dr. Xiaohong Gao: Initiating TDF at Different Gestational Weeks Safely Prevents HBV Mother-to-Child Transmission
Despite extensive research, there remains no universal consensus on the optimal timing for initiating antiviral therapy during pregnancy to prevent hepatitis B virus (HBV) mother-to-child transmission (MTCT). Divergent recommendations have…
-
CTI 2024 | ACTO Chairman Dr. Akihiro Shimosaka: Exosomes Empower Innovative Breakthroughs in Immune Cell Therapy
From November 14th to 17th, 2024, the Cellular Therapy and Immunotherapy Conference (CTI) was grandly held in Hangzhou, China, gathering top experts, scholars, and industry leaders in the field of global cell therapy and immune therapy. The conference served not only as an international platform for academic exchange but also as an important window to…
-
CTI 2024 | Dr. Leo Luznik Shares Exploration and Prospects of Bone Marrow Infiltrating T Cells in the Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
From November 14th to 17th, 2024, the Cellular Therapy and Immunotherapy Conference (CTI) was grandly held in Hangzhou, China, gathering top experts, scholars, and industry leaders in the field of global cell therapy and immune therapy. The conference served not only as an international platform for academic exchange but also as an important window to…
-
CTI 2024 | Dr. Marion Subklewe Reveals How AdCAR-T Cells Dualistically Enhance the Safety and Precision of AML Treatment
From November 14th to 17th, 2024, the Cellular Therapy and Immunotherapy Conference (CTI) was grandly held in Hangzhou, China, gathering top experts, scholars, and industry leaders in the field of global cell therapy and immune therapy. The conference served not only as an international platform for academic exchange but also as an important window to…
-
CTI 2024 | IACH Chairman Dr. Mohamad Mohty: Updates on the Latest Treatment Advances in GVHD
From November 14th to 17th, 2024, the Cellular Therapy and Immunotherapy Conference (CTI) was grandly held in Hangzhou, China, gathering top experts, scholars, and industry leaders in the field of global cell therapy and immune therapy. The conference served not only as an international platform for academic exchange but also as an important window to…
Connecting Medical Expertise through Media